QVAR antitrust class action settlement
The QVAR antitrust class action settlement is open for claims until July 31, 2026. Top Class Actions lists QVAR antitrust class action settlement as an open settlement for review. Teva Pharmaceuticals agreed to pay $35 million to resolve claims it engaged in antitrust behavior to keep its QVAR asthma medication from facing generic competition. Eligibility, proof requirements, payment amounts, and filing acceptance must be confirmed on the official claim form or settlement website before publication.
| Estimated payout | Varies |
|---|---|
| Filing deadline | July 31, 2026 3 days left |
| Proof required | Proof required |
| Who it covers | Nationwide |
| Category | Retail |
| Listed by | Top Class Actions open settlements |
Who may qualify
- Source row: QVAR antitrust class action settlement.
- Listed deadline: 2026-07-31.
- Listed payout: Varies.
- Listed proof requirement from source: Yes.
- Source status: In progress.
- You may qualify only if you meet the official class definition and submit through the official filing method.
How to file this claim
Claims for this settlement are submitted through the official, court-appointed settlement administrator. ClaimScout does not file on your behalf and never handles your payment. Open the settlement in the ClaimScout app to see the current filing requirements and go straight to the official route, plus get an alert before the deadline closes.
Related settlements
- Delphinus Engineering - Job Postings (Washington) Class Action Settlement
- Oklahoma Earthquakes Class Action Settlement
- Traeger Pellet Grills (California, Utah) Class Action Settlement
- Barefoot Dreams website tracking class action settlement
Not a law firm
ClaimScout is an independent discovery tool. Eligibility and payment amounts are decided solely by the court-appointed settlement administrator. Estimates come from public settlement documents and are not guarantees. This page is information only, not legal advice.